<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04862819</url>
  </required_header>
  <id_info>
    <org_study_id>KB776-2019</org_study_id>
    <nct_id>NCT04862819</nct_id>
  </id_info>
  <brief_title>Evaluation of a New Local Drug Delivery in the Nonsurgical Treatment of Periodontitis</brief_title>
  <official_title>Clinical, Biochemical and Microbiological Evaluation of a New Local Drug Delivery in the Nonsurgical Treatment of Periodontitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wroclaw Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wroclaw Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the planned randomized clinical trial will be the clinical and microbiological&#xD;
      evaluation of the new intracellular drug developed in cooperation with the Chair and&#xD;
      Department of Drug Form Technology of the Medical University and the Department and&#xD;
      Department of Pharmaceutical Microbiology and Parasitology of the Medical University in&#xD;
      Wrocław.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Clinical trials will be conducted on 60 patients of the Department of Periodontology of the&#xD;
      Medical University of Wrocław with 3rd or 4th degree generalized periodontitis, who will&#xD;
      consent to participate in the research by signing the documentation approved by the Bioethics&#xD;
      Committee of our University. The exclusion criteria will be: the presence of general diseases&#xD;
      affecting the clinical condition of the periodontium, hypersensitivity to the drug used in&#xD;
      the carrier system, lack of proper oral hygiene, active nicotinism and age over 65 years. The&#xD;
      research will be carried out according to the scheme of parallel randomization and&#xD;
      double-blinded trial in two groups of 30 people. All qualified patients will undergo an&#xD;
      initial period of periodontal treatment and scaling / root planning.&#xD;
&#xD;
      In the first group, on one side of the dental arch, the drug under evaluation will be used,&#xD;
      and on the other side, placebo with a change of side in every second patient. In the other&#xD;
      group, the drug under evaluation or placebo will be used on one side, and the SRP treatment&#xD;
      with alternation of sides on the other side for every second patient.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2, 2021</start_date>
  <completion_date type="Anticipated">December 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2021</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>changes in PD (pocket depth in millimetres )</measure>
    <time_frame>3 month</time_frame>
    <description>Change in depth of periodontal pockets measured from the bottom of the pocket to the edge of the gum in millimetres using periodontal probe</description>
  </primary_outcome>
  <primary_outcome>
    <measure>changes in CAL (clinical attachment level in millimetres )</measure>
    <time_frame>3 month</time_frame>
    <description>Change in clinical attachment level of periodontal pockets measured from the Cement-enamel junction to the bottom of the pocket in millimetres using periodontal probe</description>
  </primary_outcome>
  <primary_outcome>
    <measure>changes in microbiome (rt PCR test)</measure>
    <time_frame>3 month</time_frame>
    <description>change in microbiological and biochemical parameters of pocket microbiome using PCR real time test 3 months after Local dryg delivery (LDD) application( taken from the gingival pocket with gingival fluid with a paper filter. There will be six bacterial strains and the bacterial total load assessed)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Periodontitis</condition>
  <arm_group>
    <arm_group_label>scaling root planning</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients in this group will have a scaling root planing procedure only</description>
  </arm_group>
  <arm_group>
    <arm_group_label>scaling root planning with new local drug delivery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients in this group will have a scaling root planing procedure and a drug administered</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>new local drug delivery</intervention_name>
    <description>In the first group, on one side of the dental arch, the drug under evaluation will be used, and on the other side srp</description>
    <arm_group_label>scaling root planning with new local drug delivery</arm_group_label>
    <other_name>New LDD</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>scaling root planing</intervention_name>
    <description>In the second group, on one side of the dental arch srp will be performed</description>
    <arm_group_label>scaling root planning</arm_group_label>
    <arm_group_label>scaling root planning with new local drug delivery</arm_group_label>
    <other_name>Scaling root planing (gold standard treatment)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  stage- 3rd degree generalized periodontitis&#xD;
&#xD;
          -  stage 4th degree generalized periodontitis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  presence of general diseases affecting the clinical condition of the periodontium,&#xD;
&#xD;
          -  hypersensitivity to the drug used in the carrier system,&#xD;
&#xD;
          -  lack of proper oral hygiene&#xD;
&#xD;
          -  active nicotinism&#xD;
&#xD;
          -  age over 65 years&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Małgorzata Szulc, phd</last_name>
    <role>Study Director</role>
    <affiliation>wroclaw medical univeristy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tomasz Konopka, prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>wroclaw medical univeristy</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>jacek zborowski, phd</last_name>
    <phone>0048668446828</phone>
    <email>jacek.zborowski@umed.wroc.pl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Jacek Zborowski</name>
      <address>
        <city>Wrocław</city>
        <state>Dolnoslaskie</state>
        <zip>52-311</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>jacek zborowski, phd</last_name>
      <email>jacekzborowski@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wroclaw Medical University</name>
      <address>
        <city>Wrocław</city>
        <zip>52129</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Enrolling by invitation</status>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>March 2, 2021</study_first_submitted>
  <study_first_submitted_qc>April 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 28, 2021</study_first_posted>
  <last_update_submitted>April 22, 2021</last_update_submitted>
  <last_update_submitted_qc>April 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

